Epwin Group (EPWN); announces an update on the COVID-19 impact
Epwin Group announced an update on COVID-19’s impact on the group, along with its actions to mitigate it, and the results for the year ended 31 December 2019.
Read more...Walker Greenbank (WGB); releases update on Covid-19
Walker Greenbank announced that Covid-19, and government measures in its key markets to prevent the spread of the virus, is impacting its trading outlook. The company is, therefore, withdrawing financial guidance until visibility on the impact of Covid-19 improves.
Read more...Ergomed (ERGO); revenue increases 26.1% to £68.3m
Ergomed announced its full year results for the year ended 31 December 2019. Adjusted EBITDA increased 454.6% to £12.5m, while gross profit increased 53.3% to £29.5m. The order book of future contracted revenue was up 13.6% to £124.1m as of 31 December 2019, while cash and cash equivalents rose 174.8% to £14.3m.
Read more...Avon Rubber (AVON); obtains US Defense Logistics Agency body armor contract
Avon Rubber has been awarded a firm fixed price contract to supply the US Defense Logistics Agency with Enhanced Small Arms Protective Inserts (ESAPI) body armor plates. The body armor plates are a legacy product of 3M’s Ceradyne ballistic-protection business.
Read more...WANdisco (WAND); announces business update
According to the company, business momentum since its trading update in February has been very encouraging. It expects to enter full public availability with its embedded Fusion Resource Provider (FRP) product with Microsoft.
Read more...Keywords Studios (KWS); delays full-year results,
Keywords decided to delay announcing its audited results for the year ended 31 December 2019, following the two-week moratorium recently issued by the Financial Conduct Authority. The company was scheduled to release its results on 31 March 2020. The company noted some short-term disruption due to conversion of some 4,500 people to work from home arrangements.
Read more...Silence Therapeutics (SLN); announces collaboration with AstraZeneca
Silence Therapeutics announced a strategic collaboration with AstraZeneca to discover, develop and commercialize small interfering RNA (siRNA) therapeutics for the treatment of Cardiovascular, Renal, Metabolic and Respiratory diseases. AstraZeneca will make an upfront cash payment of $60m and an equity investment of $20m in Silence.
Read more...
Marshall Motors and Lookers (MMH, LOOK); announced closing of dealerships
Even ahead of the stricter controls in the UK announced by the UK Government last night, both Lookers and Marshall Motor Holdings had announced that they were to close all dealerships with immediate effect. The decision was to safeguard employees and customers and in the face of a likely sharp fall-off in activity caused by COVID-19. Both companies are focused on pre-emptive measures to preserve cash and reduce overheads costs. In this regard the help from the government initiatives to suspend business rates, defer tax payments and by the Job Retention Scheme is significant. In addition, the companies are applying self help measures such as cutting capex and suspending final dividends, and are being supported with various measures from OEM partners.
Read more...TBC Bank Group (TBCG); signs a $50m trade finance loan agreement
TBC Bank Group announced that its subsidiary, JSC TBC Bank, has signed a loan agreement for $50m with the OPEC Fund for International Development (OPEC Fund). The three-year loan facility will be used primarily to finance the international trade activities of TBC Bank customers.
Read more...YouGov (YOU); adjusted EPS up 35% to 8.7p for H1 2020
In its trading update for the six months ended 31 January 2020, YouGov, reported a 35% increase in adjusted earnings per share to 8.7p. Revenue increased by 16% to £76.9m (HY 2019: £66.5m), with underlying business growth of 15%. Adjusted operating profit rose by 35% to £11.4m (HY 2019: £8.4m), with underlying business growth of 34%. Adjusted operating profit margins improved 200bps to 15%.
Read more...